FDA Outlines Priorities For Next Five Years In Strategic Report
This article was originally published in The Gray Sheet
Executive Summary
Improving FDA's scientific know-how and regulatory tools while strengthening enforcement activities will be top priorities for the agency over the next five years, according to a new strategic report
You may also be interested in...
Regulatory News In Brief
FDA five-year strategic priorities
Regulatory News In Brief
FDA five-year strategic priorities
Regulatory News In Brief
FDA's strategic priorities